Spravato® (Esketamine)

Who Does Spravato Help?

Spravato is specifically designed for individuals who have not found relief from traditional antidepressants. It is typically prescribed for:

• Treatment-Resistant Depression (TRD): Patients who have tried at least two different antidepressants without significant improvement.
• Major Depressive Disorder (MDD) with Suicidal Ideation: Spravato is also approved for those experiencing acute suicidal thoughts, providing fast-acting relief that can be life-saving.

Spravato offers hope for individuals who have struggled to find an effective treatment for their depression.

Why Is Spravato a Beneficial Service?

Spravato provides unique benefits, making it an important option for those with treatment-resistant depression:

• Rapid Relief: While traditional antidepressants can take weeks to show effects, Spravato has been shown to reduce depressive symptoms within hours or days, offering faster relief for individuals in crisis.
• Alternative for TRD: For individuals who have tried multiple antidepressants without success, Spravato opens a new avenue of treatment, providing hope for relief from persistent depression.
• Administered in a Safe, Controlled Environment: Because Spravato can cause side effects such as dizziness or dissociation, it is administered in a clinical setting where patients are closely monitored to ensure their safety.
• Improves Mood and Functioning: Clinical trials have shown that Spravato not only reduces depressive symptoms but also improves overall functioning, allowing patients to regain their quality of life.